Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)
Objective: To analyze the MDS-UPDRS part I-IV scores and their differences based on Hoehn and Yahr stage (HY) and disease duration in a large cohort…Tremor amplitude detected by three-dimensional optical device provides good correlation to clinical rating scale
Objective: To examine the feasibility of using a three-dimensional (3D) optical device served as tremor amplitude detection, we determined correlation between its results and clinical…Pantotenate kinase associated neurodegeneration (PKAN): Proposal for a clinical rating scale
Objective: To design and validate a quantitative method for the assessment of PKAN patients. Background: Despite advances in the research of novel therapies for PKAN,…Association of Parkinson’s disease severity and cortical and subcortical cognitive markers
Objective: To assess cortical and subcortical dysfunction in several stages of Parkinson's disease (PD) using the Parkinson's disease-cognitive rating scale (PD-CRS). Background: Cognitive impairment in…Evaluating bradykinesia: How many finger taps are needed?
Objective: To assess the utility of finger tapping (FT) test to evaluate bradykinesia in Parkinson's disease (PD) at short and long FT sequences. Background: Repetitive…Cortical impairment as marker of dementia risk in probable REM sleep behavior disorder in Parkinson’s disease
Objective: To assess utility of Parkinson's disease-cognitive rating scale (PD-CRS) to detect Mild cognitive impairment (MCI) and dementia risk in a Parkinson's disease (PD) subpopulation.…Disease-related variables effect on depression and anxiety level in Parkinson’s patients
Objective: To evaluate correlations of depression and anxiety levels with motor symptoms, non-motor symptoms and pharmacological factors in Parkinson's disease (PD). Background: Depression and anxiety…Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease
Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)
Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…Clinically ‘slight’ bradykinesia in Parkinson’s disease is accurately detected using evolutionary computation analysis of finger tapping
Objective: To assess whether MDS-UPDRS grade one Parkinson's disease (PD) bradykinesia can be accurately detected by a novel non-invasive device that analyses a standard finger…